Cargando…

S101. CLINICAL FACTORS ASSOCIATED WITH CANNABIS USE IN A CHILEAN SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS

BACKGROUND: Cannabis has been associated with higher risk to develop psychosis and worse long-term outcomes. Cannabis use in 2016 is estimated to be 11.3% in Chile in 2016 (SENDA 2016). As in many other countries, cannabis use has steadily increased during last 20 years, across all socioeconomic gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iruretagoyena, Barbara, Crossley, Nicolas, Gonzalez-Valderrama, Alfonso, Mena, Cristian, Castañeda, Carmen, Diaz, Camila, Undurraga, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887953/ http://dx.doi.org/10.1093/schbul/sby018.888

Ejemplares similares

F127. GLOBAL RECOVERY IN A FIRST EPISODE PSYCHOSIS PROGRAM IN SOUTH AMERICA
por: Iruretagoyena, Barbara, et al.
Publicado: (2018)

T222. EARLY TREATMENT RESISTANCE IN A LATIN-AMERICAN COHORT OF PATIENTS WITH SCHIZOPHRENIA
por: Mena, Cristian, et al.
Publicado: (2018)

Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners
por: Undurraga, Juan, et al.
Publicado: (2021)

The incidence of non-affective psychotic disorders in Chile between 2005 and 2018: results from a national register of over 30 000 cases
por: González-Valderrama, Alfonso, et al.
Publicado: (2022)

Cannabis use during first episode psychosis in Tunisia
por: Bergaoui, E., et al.
Publicado: (2023)

F100. FACTOR STRUCTURE OF THE CANNABIS EXPERIENCES QUESTIONNAIRE IN A FIRST-EPISODE PSYCHOSIS SAMPLE
por: Birnbaum, Michael, et al.
Publicado: (2018)

Implementing Psychosocial Evidence-Based Practices in Mental Health: Are We Moving in the Right Direction?
por: González-Valderrama, Alfonso, et al.
Publicado: (2015)

Automatic language analysis identifies and predicts schizophrenia in first-episode of psychosis
por: Figueroa-Barra, Alicia, et al.
Publicado: (2022)

BDNF and Cognitive Function in Chilean Schizophrenic Patients
por: Nieto, Rodrigo R., et al.
Publicado: (2023)

Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use
por: Mhalla, Ahmed, et al.
Publicado: (2017)

F101. CANNABIS USE AND HEPATIC STEATOSIS IN PSYCHOSIS: RESULTS FROM A 3-YEAR LONGITUDINAL STUDY
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2018)

Cannabis and psychosis: Neurobiology
por: Shrivastava, Amresh, et al.
Publicado: (2014)

Cannabis Induced Psychosis
por: Bramness, J.
Publicado: (2022)

Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis
por: Oscoz-Irurozqui, Maitane, et al.
Publicado: (2023)

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
por: González-Pinto, Ana, et al.
Publicado: (2011)

The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia
por: Leeson, Verity C., et al.
Publicado: (2012)

Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis
por: González-Ortega, Itxaso, et al.
Publicado: (2015)

Cannabis use in first episode psychosis: what we have tried and why it hasn’t worked
por: McDonell, Michael G., et al.
Publicado: (2019)

S101. DIFFERENTIATING NON-AFFECTIVE ACUTE REMITTING PSYCHOSIS (NARP) FROM SCHIZOPHRENIA IN FIRST-EPISODE PSYCHOSIS: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT
por: López-Díaz, Álvaro, et al.
Publicado: (2020)

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
por: Patel, Rashmi, et al.
Publicado: (2016)

T97. CANNABIS USE IMPACTS SYMPTOM PRESENTATION IN ANTIPSYCHOTIC NAIVE PATIENTS IN FIRST EPISODE OF PSYCHOSIS (FEP)
por: Coutinho, Luccas, et al.
Publicado: (2018)

PM519. Early Cannabis Use Effects on Frontal Cortical Gamma Oscillations in First Episode Psychosis
por: Cho, Raymond, et al.
Publicado: (2016)

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2019)

S163. GLUTAMATERGIC METABOLITES IN THE PSYCHOSIS SPECTRUM: FROM HIGH RISK SAMPLES TO FIRST EPISODE PSYCHOSIS
por: Fortea, Adriana, et al.
Publicado: (2020)

Network-Level Dysconnectivity in Drug-Naïve First-Episode Psychosis: Dissociating Transdiagnostic and Diagnosis-Specific Alterations
por: Gong, Qiyong, et al.
Publicado: (2017)

Course of the Metabolic Syndrome (Mets) in a First Episode Psychosis Sample
por: Garcia De Jalon, E., et al.
Publicado: (2022)

Impact of cannabis use and cannabis cessation on inflammation in patients with psychosis
por: Romeo, B., et al.
Publicado: (2023)

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
por: Hindocha, Chandni, et al.
Publicado: (2020)

Cannabis and psychosis: what causes what?
por: Castle, David J
Publicado: (2013)

Two cases of "cannabis acute psychosis" following the administration of oral cannabis
por: Favrat, Bernard, et al.
Publicado: (2005)

Hazardous alcohol use in a sample of first episode psychosis patients in Singapore
por: Cetty, Laxman, et al.
Publicado: (2019)

The Effects of Social Determinants and Resilience on the Mental Health of Chilean Adolescents
por: Caqueo-Urízar, Alejandra, et al.
Publicado: (2023)

Sweetness of Chilean Infants’ Diets: Methodology and Description
por: González, Carmen Gloria, et al.
Publicado: (2022)

S17. ZNF804A GENE AND CANNABIS USE: INTERACTION ON THE RISK FOR PSYCHOSIS IN A NON-CLINICAL SAMPLE
por: Garcia, Jordi Soler, et al.
Publicado: (2018)

Hip Morphology Characterization: Implications in Femoroacetabular Impingement in a Chilean Population
por: Barrientos, Cristián, et al.
Publicado: (2014)

Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences
por: Setién-Suero, Esther, et al.
Publicado: (2017)

Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis
por: Schoeler, Tabea, et al.
Publicado: (2017)

S96. EXAMINING DIFFERENCES BETWEEN CURRENT CANNABIS CONSUMPTION AND COGNITIVE FUNCTIONING OF FIRST-EPISODE PSYCHOSIS PATIENTS: A RETROSPECTIVE STUDY
por: Pochiet, Gabrielle, et al.
Publicado: (2020)

M81. IQ DIFFERENCES BETWEEN PATIENTS WITH FIRST EPISODE PSYCHOSIS IN LONDON AND PALERMO REFLECT DIFFERENCES IN PATTERNS OF CANNABIS USE
Publicado: (2020)

T84. PREMORBID ADJUSTMENT AND IQ IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS: A MULTISITE CASE-CONTROL STUDY OF THEIR RELATIONSHIP WITH CANNABIS USE
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_07slp842usbkbrkr3f8t1rn6hn